An AMED-led consortium of 17 pharmaceutical companies has high hopes in AI-based drug discovery
https://bio.nikkeibp.co.jp/atcl/news/p1/24/07/29/12195/ AMED in 2019 had initiated a project where artificial
https://bio.nikkeibp.co.jp/atcl/news/p1/24/07/29/12195/ AMED in 2019 had initiated a project where artificial
https://pubs.rsc.org/en/content/articlelanding/2024/sc/d4sc02123a A research team from Tokyo University of Agriculture and
https://www.nedo.go.jp/news/press/AA5_101764.html Since 2022, NEDO supports a 10 year project for
https://bio.nikkeibp.co.jp/atcl/news/p1/24/07/18/12162/ https://www.jgc.com/jp/news/2024/20240717.html https://www.b2i.co.jp/en/ JGC Holdings (JGC HD), a large oil
https://bio.nikkeibp.co.jp/atcl/news/p1/24/01/22/11525/ https://pubmed.ncbi.nlm.nih.gov/25593106/ ITO EN and a research group led by
https://bio.nikkeibp.co.jp/atcl/news/p1/24/07/10/12134/ Cyfuse and Iwatani Corporation announced on July 10, 2024
https://www.nature.com/articles/s41586-024-07667-8 A research team from Osaka Municipal University and the
https://bio.nikkeibp.co.jp/atcl/news/p1/24/06/19/12062/ Tohoku Medical Megabank Organization (ToMMo) announced on June 19,
https://www.science.org/doi/10.1126/sciadv.adi1621 https://bio.nikkeibp.co.jp/atcl/news/p1/24/06/12/12030/ A research team at Osaka University has uncovered
https://gei.co.jp/ja/kobo/release/nedo_biofoundry_jisho0531.pdf NEDO and Green Earth Institute, Inc. (GEI) are currently